Cargando…
HJC0152 suppresses human non–small‐cell lung cancer by inhibiting STAT3 and modulating metabolism
OBJECTIVES: Signal transducer and activator of transcription 3 (STAT3) is constitutively activated and overexpressed in many cancers, including non–small‐cell lung cancer (NSCLC). We recently developed HJC0152 as an orally active STAT3 inhibitor. This study focused on investigating HJC0152's ef...
Autores principales: | Lu, Lu, Li, Hang, Wu, Xin, Rao, Jun, Zhou, Jia, Fan, Saijun, Shen, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106968/ https://www.ncbi.nlm.nih.gov/pubmed/32022328 http://dx.doi.org/10.1111/cpr.12777 |
Ejemplares similares
-
HJC0152, a novel STAT3 inhibitor with promising anti-tumor effect in gastric cancer
por: Jiang, Xiaoxia, et al.
Publicado: (2018) -
Calculation method of HJC constitutive model parameters of natural joint angle slate
por: Wan, Antong, et al.
Publicado: (2023) -
Cyanobactericidal Effect of Streptomyces sp. HJC-D1 on Microcystis auruginosa
por: Kong, Yun, et al.
Publicado: (2013) -
Smac mimetics LCL161 and GDC-0152 inhibit osteosarcoma growth and metastasis in mice
por: Shekhar, Tanmay M., et al.
Publicado: (2019) -
EHMTI-0152. Epidemiology of primary headaches among adolescents in republic of Croatia
por: Sedlic, M, et al.
Publicado: (2014)